Lv7
5000 积分 2024-07-10 加入
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
18天前
已完结
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
2个月前
已完结
Evolving Demographics of Head and Neck Mucosal Squamous Cancer
2个月前
已关闭
Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination
2个月前
已完结
Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration
3个月前
已完结
HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer
3个月前
已完结
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
3个月前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
3个月前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
3个月前
已完结
Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer
3个月前
已完结
皖公网安备34019202002308
